Clinical Trials in Nakagami, Japan
Locations / Nakagami, Japan
Delta Trials records 20 clinical trials conducted in Nakagami, Japan, making it a notable site of clinical research activity. These trials across 22 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 3 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Nakagami has changed over time.
20
Total Trials
22
Conditions
3
Terminated since 2020
Browse by condition (22 total)
- All Neovascular age-related macular degeneration trials
- Deep mycosis 1 trialAll Deep mycosis trials
- Hyperuricemia 1 trialAll Hyperuricemia trials
- Refractory reflux esophagitis 1 trialAll Refractory reflux esophagitis trials
- Onychomycosis 1 trialAll Onychomycosis trials
- Htlv-1 associated myelopathy 1 trialAll Htlv-1 associated myelopathy trials
- Trifluridine and tipiracil 1 trialAll Trifluridine and tipiracil trials
- Nonalcoholic steatohepatitis 1 trialAll Nonalcoholic steatohepatitis trials
- Hypertension 1 trialAll Hypertension trials
- Circulating tumor dna 1 trialAll Circulating tumor dna trials
- Colorectal neoplasms 1 trialAll Colorectal neoplasms trials
- All Inoperable or recurrent breast cancer trials
- Adult t-cell leukemia/lymphoma 1 trialAll Adult t-cell leukemia/lymphoma trials
- All Wet age-related macular degeneration trials
- Primary biliary cholangitis 1 trialAll Primary biliary cholangitis trials
- Functional dyspepsia 1 trialAll Functional dyspepsia trials
- All Radiotherapy-induced nausea and vomiting (rinv) trials
- Schizophrenia 1 trialAll Schizophrenia trials
- Crohn's disease 1 trialAll Crohn's disease trials
- Hidradenitis suppurativa 1 trialAll Hidradenitis suppurativa trials